Species
|
Resource
|
RRC ID
|
Title
|
Journal
|
Published
|
Link
|
Human and Animal Cells
|
JHOC-5(RCB1520)
,
JHOC-7(RCB1688)
,
JHOC-8(RCB1723)
,
JHOC-9(RCB2226)
|
61806
|
Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis.
|
PLoS One |
2013-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
JHOC-7(RCB1688)
,
JHOC-9(RCB2226)
|
61799
|
MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.
|
Oncotarget |
2016-11-15 |
Pubmed
Full text
|
DNA material
,
Human and Animal Cells
|
pCAmGCSF (RDB01522)
,
pCAZ 2 (RDB01870)
,
OV2944-HM-1(RCB1483)
|
60797
|
The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer.
|
Cancer Immunol Immunother |
2020-12-1 |
Pubmed
Full text
|
Human and Animal Cells
|
OV2944-HM-1(RCB1483)
,
JHOS-2(RCB1521)
|
52690
|
Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation.
|
Nat Commun |
2018-4-27 |
Pubmed
Full text
|
Human and Animal Cells
|
|
44821
|
Expression of chromobox homolog 7 (CBX7) is associated with poor prognosis in ovarian clear cell adenocarcinoma via TRAIL-induced apoptotic pathway regulation.
|
Int J Cancer |
2014-7-15 |
Pubmed
Full text
|
Human and Animal Cells
|
JHOC-9(RCB2226)
,
JHOC-5(RCB1520)
|
44070
|
Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer.
|
Am J Clin Pathol |
2012-10-1 |
Pubmed
Full text
|
Human and Animal Cells
|
JHOC-9(RCB2226)
,
JHOC-5(RCB1520)
|
43906
|
Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma.
|
Hum Pathol |
2012-12-1 |
Pubmed
Full text
|
Human and Animal Cells
|
JHOC-9(RCB2226)
|
38446
|
Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma.
|
Cancer |
2012-6-1 |
Pubmed
Full text
|